Systematic Detection of Pathogenic Alu Element Insertions in NGS-Based Diagnostic Screens: The BRCA1/BRCA2 Example

被引:13
作者
De Brakeleer, Sylvia [1 ]
De Greve, Jacques [1 ]
Lissens, Willy [2 ,3 ]
Teugels, Erik [1 ]
机构
[1] Vrije Univ Brussel, Lab Mol & Med Oncol, B-1090 Brussels, Belgium
[2] UZ Brussel, Ctr Med Genet, Brussels, Belgium
[3] Vrije Univ Brussel, B-1090 Brussels, Belgium
关键词
Alu insertion; NGS; BRCA1; BRCA2; mutation screen; BREAST-CANCER; BRCA2; REARRANGEMENT; MUTATIONS; GENES; FAMILIES;
D O I
10.1002/humu.22297
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pathogenic Alu element insertions are rarely reported, whereas their occurrence is expected to be much higher. Alu containing alleles are usually out-competed during the PCR process and consequently undetectable with the classical screening methods. However, with the introduction of the next generation sequencing (NGS) technology in the diagnostic field, new opportunities are emerging. NGS data for a particular genomic region can be seen as the summation of all the individual sequences (reads) obtained for that region and no longer as the mean of this sum as it is the case for traditional Sanger sequencing. Because each single read covering that region is expected to be generated from a different template molecule, the presence of one single mutant read must theoretically be sufficient to identify the mutation. However, generation and identification of mutant reads bearing Alu insertions remains challenging and several wet/dry bench parameters need to be optimized. Hereby we present the proof of principle of a NGS-based mutation screening procedure allowing the detection of inherited Alu insertions within any predefined sequence by investigating 2 cases: c.1739_1740insAlu in BRCA1 and c.156_157insAlu in BRCA2.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 16 条
  • [1] Hereditary breast cancer: from bench to bedside
    De Greve, Jacques
    Sermijn, Erica
    De Brakeleer, Sylvia
    Ren, Zhuo
    Teugels, Erik
    [J]. CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 605 - 613
  • [2] Massive Parallel Amplicon Sequencing of the Breast Cancer Genes BRCA1 and BRCA2: Opportunities, Challenges, and Limitations
    De Leeneer, Kim
    Hellemans, Jan
    De Schrijver, Joachim
    Baetens, Machteld
    Poppe, Bruce
    Van Criekinge, Wim
    De Paepe, Anne
    Coucke, Paul
    Claes, Kathleen
    [J]. HUMAN MUTATION, 2011, 32 (03) : 335 - 344
  • [3] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [4] Detection of Genomic Variations in BRCA1 and BRCA2 Genes by Long-Range RCA and Next-Generation Sequencing
    Hernan, Imma
    Borras, Emma
    de Sousa Dias, Miguel
    Jose Gamundi, Maria
    Mane, Begona
    Llort, Gemma
    Agundez, Jose A. G.
    Blanca, Miguel
    Carballo, Miguel
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (03) : 286 - 293
  • [5] Hogervorst FBL, 2003, CANCER RES, V63, P1449
  • [6] Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families:: Evidence for a founder effect and analysis of the associated phenotypes
    Machado, Patricia M.
    Brandao, Rita D.
    Cavaco, Branca M.
    Eugenio, Joana
    Bento, Sandra
    Nave, Monica
    Rodrigues, Paula
    Fernandes, Aires
    Vaz, Fatima
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2027 - 2034
  • [7] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
    Meijers-Heijboer, H
    van den Ouweland, A
    Klijn, J
    Wasielewski, M
    de Snoo, A
    Oldenburg, R
    Hollestelle, A
    Houben, M
    Crepin, E
    van Veghel-Plandsoen, M
    Elstrodt, F
    van Duijn, C
    Bartels, C
    Meijers, C
    Schutte, M
    McGuffog, L
    Thompson, D
    Easton, DF
    Sodha, N
    Seal, S
    Barfoot, R
    Mangion, J
    Chang-Claude, J
    Eccles, D
    Eeles, R
    Evans, DG
    Houlston, R
    Murday, V
    Narod, S
    Peretz, T
    Peto, J
    Phelan, C
    Zhang, HX
    Szabo, C
    Devilee, P
    Goldgar, D
    Futreal, PA
    Nathanson, KL
    Weber, BL
    Rahman, N
    Stratton, MR
    [J]. NATURE GENETICS, 2002, 31 (01) : 55 - 59
  • [8] Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon-Based Massive Parallel Pyrosequencing
    Michils, Genevieve
    Hollants, Silke
    Dehaspe, Luc
    Van Houdt, Jeroen
    Bidet, Yannick
    Uhrhammer, Nancy
    Bignon, Yves-Jean
    Vermeesch, Joris R.
    Cuppens, Harry
    Matthijs, Gert
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06) : 623 - 630
  • [9] Mutation analysis in the BRCA2 gene in primary breast cancers
    Miki, Y
    Katagiri, T
    Kasumi, F
    Yoshimoto, T
    Nakamura, Y
    [J]. NATURE GENETICS, 1996, 13 (02) : 245 - 247
  • [10] Genetic Diagnosis of Familial Breast Cancer Using Clonal Sequencing
    Morgan, Joanne E.
    Carr, Ian M.
    Sheridan, Eamonn
    Chu, Carol E.
    Hayward, Bruce
    Camm, Nick
    Lindsay, Helen A.
    Mattocks, Chris J.
    Markham, Alexander F.
    Bonthron, David T.
    Taylor, Graham R.
    [J]. HUMAN MUTATION, 2010, 31 (04) : 484 - 491